Found 5 matching trials
A Study of OV101 in Individuals With Angelman Syndrome (AS)
PHASE3The purpose of this study is to assess the efficacy and safety of oral OV10...
Location
Ovid Therapeutics Investigative Site
A Study in Adults and Adolescents With Angelman Syndrome (STARS)
PHASE2The purpose of the study is to assess the safety and tolerability of oral O...
Location
Ovid Therapeutics Investigative Site
An Open-Label Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of OV101 in Individuals With Angelman Syndrome
PHASE3This open-label study (OV101-18-002) will evaluate the long-term (52 weeks)...
Location
Ovid Therapeutics Investigative Site
A Study of OV101 in Individuals With Fragile X Syndrome
PHASE2The purpose of this study is to assess the safety, tolerability and efficac...
Location
Ovid Therapeutics Investigative Site
Single Dose Pharmacokinetic (PK) Study
PHASE1The trial is a Phase 1 Single Dose PK Study in Adolescent Subjects with Fra...
Location
Ovid Therapeutics Investigative Site